Squarepoint
IDYA icon

Squarepoint’s IDEAYA Biosciences IDYA Stock Holding History

Squarepoint’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.31M Buy
+99,278
New +$3.33M ﹤0.01% 1813
2025
Q4 		– Sell
-104,666
Closed -$2.85M – 4538
2025
Q3 		$2.85M Buy
104,666
+67,277
+180% +$1.63M ﹤0.01% 1827
2025
Q2 		$786K Sell
37,389
-51,937
-58% -$996K ﹤0.01% 2879
2025
Q1 		$1.46M Sell
89,326
-89,566
-50% -$1.91M ﹤0.01% 2329
2024
Q4 		$4.6M Buy
178,892
+33,088
+23% +$937K ﹤0.01% 1709
2024
Q3 		$4.62M Buy
145,804
+45,302
+45% +$1.72M 0.01% 1470
2024
Q2 		$3.53M Buy
100,502
+56,256
+127% +$2.23M 0.01% 1619
2024
Q1 		$1.94M Buy
44,246
+19,668
+80% +$846K ﹤0.01% 2090
2023
Q4 		$874K Buy
24,578
+12,206
+99% +$364K ﹤0.01% 2621
2023
Q3 		$334K Buy
+12,372
New +$314K ﹤0.01% 3089
2023
Q2 		– Sell
-19,336
Closed -$265K – 3759
2023
Q1 		$265K Sell
19,336
-36,600
-65% -$610K ﹤0.01% 2644
2022
Q4 		$1.02M Buy
55,936
+38,059
+213% +$640K ﹤0.01% 1816
2022
Q3 		$267K Buy
17,877
+7,033
+65% +$91.3K ﹤0.01% 2545
2022
Q2 		$150K Sell
10,844
-9,266
-46% -$103K ﹤0.01% 2549
2022
Q1 		$225K Buy
+20,110
New +$296K ﹤0.01% 2424
2021
Q2 		– Sell
-23,740
Closed -$558K – 3443
2021
Q1 		$558K Sell
23,740
-7,156
-23% -$138K ﹤0.01% 1940
2020
Q4 		$433K Sell
30,896
-35,405
-53% -$480K ﹤0.01% 1914
2020
Q3 		$833K Buy
66,301
+50,292
+314% +$623K 0.01% 1088
2020
Q2 		$227K Buy
16,009
+3,608
+29% +$28.4K ﹤0.01% 1761
2020
Q1 		$51K Sell
12,401
-6,685
-35% -$47.3K ﹤0.01% 1719
2019
Q4 		$143K Buy
19,086
+5,954
+45% +$42.5K ﹤0.01% 2295
2019
Q3 		$118K Buy
+13,132
New +$100K ﹤0.01% 2168

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Squarepoint's IDYA Position: Q1 2026 in Review

Squarepoint opened a new position in IDEAYA Biosciences (IDYA) in Q1 2026: 99,278 shares worth $3.31M. The stake represents ﹤0.01% of the portfolio and ranks #1813 among its holdings. This is a return to the name: Squarepoint previously reported a position in IDYA as recently as Q3 2025.

Squarepoint first reported a position in IDYA in Q3 2019 and has held it in 22 quarters since. The position peaked at $4.62M in Q3 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Squarepoint held 99,278 shares of IDEAYA Biosciences worth $3.31M as of Q1 2026.
  • IDEAYA Biosciences was a new Squarepoint position in Q1 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1813 holding.
  • Squarepoint first reported a position in IDEAYA Biosciences in Q3 2019 and has held it in 22 quarters since.
  • Squarepoint's IDEAYA Biosciences position peaked at $4.62M in Q3 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.